Sector Gamma ASA
Latest statistics and disclosures from Sector Gamma As's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MDT, PFE, BMY, CVS, CAH, and represent 40.11% of Sector Gamma As's stock portfolio.
- Added to shares of these 10 stocks: UHS (+$13M), CVS (+$7.1M), BMY (+$6.7M), VTRS, AGIO, QGEN, PFE, BIO, ELV, CAH.
- Started 4 new stock positions in VTRS, UHS, AGIO, QGEN.
- Reduced shares in these 10 stocks: CNC (-$15M), THC (-$12M), , GEHC (-$11M), BIIB (-$9.2M), GILD (-$8.6M), Qiagen Nv (-$8.3M), EW (-$7.7M), INCY (-$7.6M), GMED (-$6.9M).
- Sold out of its positions in ABT, ACAD, LH, RARE, VIR, Qiagen Nv.
- Sector Gamma As was a net seller of stock by $-69M.
- Sector Gamma As has $355M in assets under management (AUM), dropping by -13.91%.
- Central Index Key (CIK): 0001475373
Tip: Access up to 7 years of quarterly data
Positions held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 28 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Medtronic SHS (MDT) | 10.1 | $36M | -5% | 412k | 87.15 |
|
| Pfizer (PFE) | 9.7 | $34M | +13% | 1.2M | 27.75 |
|
| Bristol Myers Squibb (BMY) | 7.6 | $27M | +33% | 499k | 54.23 |
|
| CVS Caremark Corporation (CVS) | 6.9 | $25M | +40% | 308k | 79.76 |
|
| Cardinal Health (CAH) | 5.8 | $20M | +11% | 183k | 111.90 |
|
| Gilead Sciences (GILD) | 5.5 | $20M | -30% | 266k | 73.25 |
|
| Anthem (ELV) | 5.0 | $18M | +23% | 34k | 518.54 |
|
| Zimmer Holdings (ZBH) | 4.5 | $16M | -14% | 121k | 131.98 |
|
| Incyte Corporation (INCY) | 4.3 | $15M | -33% | 265k | 56.97 |
|
| Baxter International (BAX) | 3.9 | $14M | 323k | 42.74 |
|
|
| Biogen Idec (BIIB) | 3.6 | $13M | -41% | 60k | 215.63 |
|
| Universal Hlth Svcs CL B (UHS) | 3.6 | $13M | NEW | 70k | 182.46 |
|
| Bio Rad Labs Cl A (BIO) | 3.3 | $12M | +42% | 34k | 345.87 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 3.2 | $11M | -50% | 123k | 90.91 |
|
| Bruker Corporation (BRKR) | 3.0 | $11M | -11% | 113k | 93.94 |
|
| Edwards Lifesciences (EW) | 2.9 | $10M | -43% | 107k | 95.56 |
|
| Tenet Healthcare Corp Com New (THC) | 2.3 | $8.1M | -59% | 78k | 105.11 |
|
| Ionis Pharmaceuticals (IONS) | 2.1 | $7.6M | +21% | 176k | 43.35 |
|
| BioMarin Pharmaceutical (BMRN) | 2.0 | $7.1M | -5% | 81k | 87.34 |
|
| Alkermes SHS (ALKS) | 1.9 | $6.8M | +26% | 252k | 27.07 |
|
| Globus Med Cl A (GMED) | 1.6 | $5.7M | -55% | 105k | 53.64 |
|
| Viatris (VTRS) | 1.4 | $5.0M | NEW | 418k | 11.94 |
|
| Agios Pharmaceuticals (AGIO) | 1.4 | $4.8M | NEW | 164k | 29.24 |
|
| Qiagen Nv Shs New (QGEN) | 1.3 | $4.4M | NEW | 103k | 42.99 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $4.1M | -14% | 28k | 149.45 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.9 | $3.3M | 53k | 62.24 |
|
|
| Illumina (ILMN) | 0.7 | $2.3M | -58% | 17k | 137.32 |
|
| Centene Corporation (CNC) | 0.5 | $1.7M | -89% | 22k | 78.48 |
|
Past Filings by Sector Gamma As
SEC 13F filings are viewable for Sector Gamma As going back to 2010
- Sector Gamma As 2024 Q1 filed May 8, 2024
- Sector Gamma As 2023 Q4 filed Feb. 5, 2024
- Sector Gamma As 2023 Q3 filed Nov. 6, 2023
- Sector Gamma As 2023 Q2 filed Aug. 9, 2023
- Sector Gamma As 2023 Q1 filed May 12, 2023
- Sector Gamma As 2022 Q4 restated filed Feb. 8, 2023
- Sector Gamma As 2022 Q4 filed Feb. 7, 2023
- Sector Gamma As 2022 Q3 filed Nov. 9, 2022
- Sector Gamma As 2022 Q2 filed Aug. 5, 2022
- Sector Gamma As 2022 Q1 filed May 6, 2022
- Sector Gamma As 2021 Q4 filed Feb. 8, 2022
- Sector Gamma As 2021 Q3 filed Oct. 29, 2021
- Sector Gamma As 2021 Q2 filed Aug. 4, 2021
- Sector Gamma As 2021 Q1 filed May 10, 2021
- Sector Gamma As 2020 Q4 filed Feb. 10, 2021
- Sector Gamma As 2020 Q3 filed Nov. 9, 2020